| Last Action | 02/08/19: to Health & Welfare (S) |
|---|---|
| Title | AN ACT relating to discussion with patients on the risks, benefits, and limitations of treatment with controlled substances. |
| Bill Documents | Introduced |
| Bill Request Number | 1107 |
| Sponsor | A. Kerr |
| Summary of Original Version | Amend KRS 218A.172 to add issues that a practitioner is required to discuss with a patient prior to prescribing or dispensing a controlled substance to a patient; require that the same information is discussed prior to a third sequential prescription; require any discussion records to be kept by the practitioner. |
| Index Headings of Original Version |
Drugs and Medicines - Controlled substances, risks, benefits, limitations, practititioner discussion with patient Health and Medical Services - Controlled substances, risks, benefits, limitations, practititioner discussion with patient Nurses - Controlled substances, risks, benefits, limitations, discussion with patient Pharmacists - Controlled substances, risks, benefits, limitations, discussion with patient Physicians and Practitioners - Controlled substances, risks, benefits, limitations, discussion with patient |
| 02/05/19 |
|
|---|---|
| 02/08/19 |
|
Last updated: 11/9/2023 3:08 PM (EST)